May 12 (Reuters)-
Trans Genic Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2023 Mar 31, 2022 Mar 31, 2024 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 11.43 12.58 12.50
(-9.1 pct) (+13.9 pct) (+9.4 pct)
Operating loss 25 mln 1.84 300 mln
(+105.7 pct)
Recurring 199 mln 1.82 250 mln
(-89.0 pct) (+104.0 pct) (+25.5 pct)
Net
Net loss 409 mln 1.88 150 mln
(+243.5 pct)
EPS loss 24.32 yen 109.52 yen 8.90 yen
EPS Diluted 109.31 yen
Ann Div 5.00 yen 6.00 yen 3.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 5.00 yen 6.00 yen 3.00 yen
NOTE - Trans Genic Inc.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2342.T